|Videos|December 29, 2022
Importance of Screening for T1D
Tina Q Tan, MD, and Kimberly Simmons, MD, comment on early screening for pediatric T1D, screening options, and next steps once a child has tested positive for 2 or more autoantibodies.
Advertisement
Episodes in this series
Advertisement
Related to this article
Brittany S. Bruggeman, MD, reviews teplizumab (Tzield), islet autoantibody screening, and automated insulin delivery, and how pediatricians can help families.
Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Type 1 diabetes update: Immune therapy, screening, and new technology
2
Adolescent suicidal ideation trend reversed around 2009, analysis finds
3
What pediatricians should know about the 2026-27 AAP vaccine schedule
4
Constipation may be an overlooked driver of urinary symptoms in children
5